860798 | CP-LC-1067
Octyl 2-methyl-14-((3-(octyloxy)-3-oxopropyl)thio)-6,9-dioxo-7-(2-((3-oxo-3-(tridecyloxy)propyl)thio)ethyl)-17-thia-2,5,8-triazaicosan-20-oate

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
CP-LC-1067
Octyl 2-methyl-14-((3-(octyloxy)-3-oxopropyl)thio)-6,9-dioxo-7-(2-((3-oxo-3-(tridecyloxy)propyl)thio)ethyl)-17-thia-2,5,8-triazaicosan-20-oate
Manufactured and Distributed under License from Certest Biotec S.L
Compared to industry-leading lipid nanoparticle (LNP) formulations which have a primary biodistribution in the liver, LNPs formulated using the ionizable lipid CP-LC-1067 exhibit targeted lung tissue selectivity.
pKa in formulation = 8.45 (measured by TNS)
C54H103N3O8S3 |